Click on a link to view a PDF of the full press release

November 16, 2009

Winston Laboratories, Inc. Announces Positive Top-line Results of Phase II

November 10, 2009

Winston Pharmaceuticals, Inc. To Present at Lazard Capital Markets 6th Annual Healthcare Conference

October 19, 2009

Winston Laboratories, Inc. Receives Notice of Non-Compliance in Canada for its New Drug Submission of CIVANEX to Treat Osteoarthritis

August 14, 2009

Winston Pharmaceuticals, Inc. Announces Re-Election of Joel E. Bernstein M.D. as President and Chief Executive Officer

July 28, 2009

Winston Pharmaceuticals, Inc. Announces Election of New Chief Executive Officer and Chairman of the Board of Directors

February 24, 2009

Winston Pharmaceuticals, Inc. Receives Orphan Drug Designation for Novel Patch to Treat Post-Herpetic Neuralgia

February 9, 2009

Winston Pharmaceuticals, Inc. Announces Positive Top-line Results of Phase I Clinical Trial of Civamide Patch

January 15, 2009

Winston Pharmaceuticals, Inc. (Formerly Getting Ready Corporation) commences trading under new name and stock symbol

November 5, 2008

Winston Laboratories, Inc. Announces Licensing Agreement with Sanofi-Aventis Canada Inc, In Canada

September 25, 2008

Getting Ready Corporation and Winston Laboratories, Inc. Announce Completion of Merger

November 15, 2007

Getting Ready Corporation and Winston Laboratories, Inc. Announce Merger Agreement